Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020437 (
hypercalcemia
)
10,293
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
24R,25(OH)2D3, one of the endogenous active metabolites of vitamin D3, showed suppressive effects on the proliferation of various tumor cells in vitro and a prolonging effect on the survival of P-388 bearing mice in vivo. Lewis lung carcinoma was found to cause
hypercalcemia
in tumor bearing mice.
K-DR
(24R,25(OH)2D3 (prepared by Kureha Chemical Ind.) significantly prolonged the survival of mice with Lewis lung carcinoma.
K-DR
also showed a suppressive effect on the growth of human osteosarcoma transplanted in nude mice.
...
PMID:Antitumor effect of 24R,25-dihydroxyvitamin D3. 297 28
Lewis lung carcinoma was found to cause
hypercalcaemia
in tumour-bearing mice.
24R,25-Dihydroxyvitamin D3
, a naturally occurring steric epimer, significantly prolonged the survival time of mice with Lewis lung carcinoma. It also had an analgesic effect in mice with Lewis lung carcinoma and increased the strength of bone weakened by the carcinoma which causes abnormal calcium metabolism and results in
hypercalcaemia
.
...
PMID:Animal pharmacological effects of 24R,25-dihydroxyvitamin D3 one of the endogenous substances regulating calcium metabolism. 325 37
Lewis lung carcinoma was found to cause
hypercalcemia
in tumor-bearing mice. 24R,25(OH)2D3 (
K-DR
, prepared by Kureha Chemical Ind.) significantly prolonged the survival time of mice with Lewis lung carcinoma.
K-DR
exhibited an antimetastatic effect on Lewis lung carcinoma, and also had an analgesic effect in mice with Lewis lung carcinoma.
...
PMID:Antitumor and other effects of 24R,25-dihydroxycholecalciferol in Lewis lung carcinoma causing abnormal calcium metabolism in tumor-bearing mice. 336 96